Home LiteratureArticle Details
PMID: 15781870 Published · ppublish English Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization.

Malley R, Trzcinski K, Srivastava A, Thompson CM, Anderson PW, Lipsitch M

Abstract

Acquired immunity to Streptococcus pneumoniae (pneumococcus) has long been assumed to depend on the presence of anticapsular antibodies. We found, however, that colonization with live pneumococci of serotypes 6B, 7F, or 14 protected mice against recolonization by any of the serotypes and that protection from acquisition of a heterologous or homologous strain did not depend on anticapsular antibody. Further, intranasal immunization by live pneumococcal colonization or by a killed, nonencapsulated whole-cell vaccine protected antibody-deficient mice against colonization, suggesting independence of antibodies to any pneumococcal antigens. Protection by intranasal immunization with whole-cell vaccine was completely abrogated in T cell-deficient mice, and in mice that were congenitally deficient in CD4(+) T cells or depleted of these cells at the time of challenge. In contrast, mice congenitally deficient in, or depleted of, CD8(+) T cells were fully protected. Protection in this model was observed beyond 2 months after immunization, arguing against innate or nonspecific immune mechanisms. Thus, we find that immunity to pneumococcal colonization can be induced in the absence of antibody, independent of the capsular type, and this protection requires the presence of CD4(+) T cells at the time of challenge.

MeSH Terms
Administration, Intranasal Animals CD4-Positive T-Lymphocytes/immunology Enzyme-Linked Immunosorbent Assay Female Immunity, Cellular Mice Mice, Inbred C57BL Pneumococcal Infections/prevention & control Species Specificity Streptococcal Vaccines/administration & dosage,immunology Streptococcus pneumoniae/immunology Time Factors
Chemicals
Streptococcal Vaccines
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Malley Richard
Division of Infectious Diseases, Department of Medicine, Children's Hospital and Harvard Medical School, Boston, MA 02115, USA. richard.malley@childrens.harvard.edu
Trzcinski Krzysztof
Srivastava Amit
Thompson Claudette M
Anderson Porter W
Lipsitch Marc
References (34)
34 references, click to expand
  1. Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos.
    J Immunol. 2003 Nov 15;171(10):4984-9 PMID: 14607893
  2. Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease?
    PLoS Med. 2005 Jan;2(1):e15 PMID: 15696204
  3. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.
    Pediatrics. 2004 Mar;113(3 Pt 1):443-9 PMID: 14993532
  4. CD4-T-lymphocyte interactions with pneumolysin and pneumococci suggest a crucial protective role in the host response to pneumococcal infection.
    Infect Immun. 2004 May;72(5):2689-97 PMID: 15102777
  5. Multiserotype protection of mice against pneumococcal colonization of the nasopharynx and middle ear by killed nonencapsulated cells given intranasally with a nontoxic adjuvant.
    Infect Immun. 2004 Jul;72(7):4290-2 PMID: 15213177
  6. Primary induction of CD4 T cell responses in nasal associated lymphoid tissue during group A streptococcal infection.
    Eur J Immunol. 2004 Oct;34(10):2843-53 PMID: 15368301
  7. Limited role of antibody in clearance of Streptococcus pneumoniae in a murine model of colonization.
    Infect Immun. 2004 Oct;72(10):5807-13 PMID: 15385481
  8. Interleukin-17 family members and inflammation.
    Immunity. 2004 Oct;21(4):467-76 PMID: 15485625
  9. X-linked agammaglobulinemia: an analysis of 96 patients.
    Medicine (Baltimore). 1985 May;64(3):145-56 PMID: 2581110
  10. Immunization of 2-month-old infants with protein-coupled oligosaccharides derived from the capsule of Haemophilus influenzae type b.
    J Pediatr. 1985 Sep;107(3):346-51 PMID: 3875705
  11. Some aspects of the pneumococcal carrier state.
    J Antimicrob Chemother. 1986 Jul;18 Suppl A:35-45 PMID: 3745031
  12. Ultrastructural localization of capsules, cell wall polysaccharide, cell wall proteins, and F antigen in pneumococci.
    Infect Immun. 1988 Aug;56(8):1890-6 PMID: 3397179
  13. Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells.
    Nature. 1990 Apr 19;344(6268):742-6 PMID: 2139497
  14. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene.
    Nature. 1991 Apr 4;350(6317):423-6 PMID: 1901381
  15. Mice lacking major histocompatibility complex class I and class II molecules.
    Proc Natl Acad Sci U S A. 1993 May 1;90(9):3913-7 PMID: 8483910
  16. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor.
    Nature. 1995 Oct 5;377(6548):435-8 PMID: 7566121
  17. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine.
    J Infect Dis. 1996 Dec;174(6):1271-8 PMID: 8940218
  18. Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae.
    J Infect Dis. 1998 Feb;177(2):368-77 PMID: 9466523
  19. Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory.
    Pediatr Infect Dis J. 1998 Mar;17(3):211-6 PMID: 9535248
  20. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients.
    Science. 1998 May 29;280(5368):1435-8 PMID: 9603733
  21. Th1 cells specific for a secreted protein of Listeria monocytogenes are protective in vivo.
    J Immunol. 1998 Jun 15;160(12):6046-55 PMID: 9637521
  22. Anticapsular polysaccharide antibodies and nasopharyngeal colonization with Streptococcus pneumoniae in infant rats.
    J Infect Dis. 1998 Sep;178(3):878-82 PMID: 9728564
  23. Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA).
    Clin Microbiol Rev. 1998 Oct;11(4):645-57 PMID: 9767061
  24. Host cellular immune response to pneumococcal lung infection in mice.
    Infect Immun. 2000 Feb;68(2):492-501 PMID: 10639409
  25. Depletion of CD8+ cells abolishes memory in acquired immunity against Chlamydia pneumoniae in BALB/c mice.
    Immunology. 1999 Jul;97(3):490-6 PMID: 10447772
  26. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group.
    Pediatr Infect Dis J. 2000 Mar;19(3):187-95 PMID: 10749457
  27. Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media.
    J Infect Dis. 2000 Oct;182(4):1146-52 PMID: 10979911
  28. Efficacy of a pneumococcal conjugate vaccine against acute otitis media.
    N Engl J Med. 2001 Feb 8;344(6):403-9 PMID: 11172176
  29. Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci.
    Infect Immun. 2001 Aug;69(8):4870-3 PMID: 11447162
  30. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection.
    Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1966-71 PMID: 12569171
  31. Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection.
    J Immunol. 2003 May 1;170(9):4432-6 PMID: 12707317
  32. The potential indirect effect of conjugate pneumococcal vaccines.
    Vaccine. 2003 May 16;21(17-18):1815-25 PMID: 12706665
  33. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.
    N Engl J Med. 2003 May 1;348(18):1737-46 PMID: 12724479
  34. Construction of otherwise isogenic serotype 6B, 7F, 14, and 19F capsular variants of Streptococcus pneumoniae strain TIGR4.
    Appl Environ Microbiol. 2003 Dec;69(12):7364-70 PMID: 14660386
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2005-03-29
Epub
2005-00-21
Pages
4848-53
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC555733
Subset
IM
Grants
NIAID NIH HHS · T32 AI007061 · United States
NIAID NIH HHS · K08 AI51526-01 · United States
NIAID NIH HHS · K08 AI051526 · United States
NIAID NIH HHS · R01 AI048935 · United States
NIAID NIH HHS · AI07061-26 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com